Welcome to our dedicated page for Semler Scientific SEC filings (Ticker: SMLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Semler Scientific, Inc. (Nasdaq: SMLR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents cover both its healthcare operations and its Bitcoin treasury activities, offering investors insight into how the company reports revenues and expenses from its medical device and software business alongside unrealized gains and losses from changes in the fair value of its Bitcoin holdings.
In its periodic reports, Semler Scientific presents financial statements that reflect income from operations in its healthcare segment, operating expenses such as engineering and product development, sales and marketing, and general and administrative costs, as well as line items related to digital assets. The filings detail the fair value of Bitcoin classified as intangible digital assets, changes in that fair value, and the impact on pre-tax income. They also describe capital-raising transactions, including at-the-market equity offering programs and 4.25% convertible senior notes due 2030, and provide information on stockholders’ equity.
Current reports on Form 8-K document material events such as the adoption and evolution of Semler Scientific’s Bitcoin treasury strategy, the master loan agreement with Coinbase Credit Inc. secured by Bitcoin collateral, and the agreement in principle to settle a civil investigative demand from the U.S. Department of Justice. Other 8-K filings describe a strategic plan to realign operations through headcount reductions and expense curtailment, a non-executive retention program, executive officer changes and the Agreement and Plan of Merger providing for the acquisition of Semler Scientific by Strive, Inc. in an all-stock transaction.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly identify items such as segment performance, digital asset disclosures, capital structure changes and merger-related information. Investors can also use the filings to monitor topics like BTC Yield as a disclosed key performance indicator, the structure of Bitcoin-related financing arrangements and other regulatory disclosures relevant to SMLR.
Strive, Inc. reposted a communication related to its proposed business combination with Semler Scientific, Inc. The notice includes a comprehensive cautionary statement about forward‑looking statements and highlights risks and uncertainties that could cause actual results to differ.
Strive has filed a Form S-4 Registration Statement to register Class A common stock to be issued in connection with the transaction. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. Investors are directed to the SEC’s website and company investor sites for free access to these materials.
The communication also states it is not an offer or solicitation to buy or sell securities, and that any offer will only be made by a prospectus meeting Securities Act requirements or pursuant to an applicable exemption.
Strive, Inc. shared a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). Strive has filed a Form S-4 registration statement to register Class A common stock to be issued in the transaction, which will include an Information Statement/Proxy Statement/Prospectus. Semler stockholders will receive these materials to consider and vote on the proposed deal.
The communication includes standard forward‑looking statements and risk cautions, notes that certain directors and officers may be participants in the proxy solicitation, and provides links to obtain SEC filings at no cost. It also states this is not an offer or solicitation to buy or sell securities; any offer will be made only by a prospectus meeting Securities Act requirements.
Strive, Inc. announced a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction. A combined information statement, proxy statement, and prospectus will be sent to Semler Scientific stockholders to seek approval. The communication includes cautionary forward-looking statements, identifies potential proxy participants, and states that no offer or solicitation is being made. Investors are directed to the SEC’s website and company investor pages for the S-4 and related materials.
Strive, Inc. shared a communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). The companies note that a Form S-4 registration statement has been filed to register Strive Class A common stock to be issued in the transaction and will include an information statement, proxy statement, and prospectus.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes customary forward‑looking statements and urges investors to read SEC filings when available for important details.
Strive, Inc. filed investor communications for its proposed business combination with Semler Scientific (SMLR), sharing details from a recent podcast on its capital structure and preferred equity strategy. Strive highlighted the IPO of its perpetual preferred, SATA, which was upsized from $125 million to $200 million and initially offered at $80 per share with a 12% stated dividend on a $100 stated amount.
The company discussed managing SATA to trade near $100, with a target range of $95–$105, a dividend rate floor at 1‑month SOFR, cumulative dividends with step-up penalties up to 20% if suspended, a call feature at $110, and a policy not to reduce the dividend when trading below $99. Strive also noted a 12‑month dividend reserve held in cash.
Proceeds were used to expand Bitcoin holdings to 7,525 BTC. Illustrative coverage metrics cited include Bitcoin holdings of roughly 3.8x the SATA notional and about 32.7x annual dividend coverage, based on an example with $200 million preferred outstanding and $24 million annual dividends. The discussion reiterated the planned combination with Semler, which was described as holding more than 5,000 BTC, and emphasized perpetual preferred equity as a core financing tool.
Strive, Inc. filed a communication under Rule 425 regarding its proposed business combination with Semler Scientific, Inc. (SMLR), reposted on X.com by a Strive board member. The notice emphasizes forward‑looking statement cautions and references risks that could cause actual results to differ materially.
Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction, which will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval.
The communication directs investors to the SEC’s website and each company’s investor relations pages for the Registration Statement and related materials, notes potential participants in the solicitation, and states that this is not an offer or solicitation to sell or buy securities.
Semler Scientific (SMLR) issued a Rule 425 communication regarding the proposed acquisition of Semler Scientific by Strive, Inc. Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, and an Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval.
Investors are urged to read the Registration Statement and related materials when available. Documents will be accessible at the SEC’s website and through Strive’s and Semler Scientific’s investor relations pages. The communication notes that Strive, Semler Scientific, and certain of their directors and officers may be participants in the proxy solicitation, includes customary “no offer or solicitation” language, and provides a cautionary statement regarding forward‑looking statements and referenced risk factors.
Strive, Inc. posted an investor presentation under Rule 425 regarding its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders. Investors are urged to read these materials when available. Documents can be obtained free of charge from the SEC’s website and the companies’ investor sites. This communication is not an offer or solicitation to buy or sell securities.
Semler Scientific filed an 8-K noting its pending all-stock merger with Strive, Inc. and providing supplemental details on Strive’s recent financing and asset purchases. Strive closed an IPO of 2,000,000 shares of its Variable Rate Series A Perpetual Preferred Stock at $80 per share, generating net proceeds of $149.3 million.
Strive used proceeds to purchase bitcoin and for general corporate purposes. Between October 28 and November 9, 2025, Strive acquired approximately 1,567.2 bitcoin at an average price of $103,315.46 per bitcoin, for a total of $161,912,220 including fees. Following these transactions, Strive holds about 7,525 bitcoin, with a total acquisition cost of $853,218,300 and an average acquisition price of $113,384.18 per bitcoin.
Semler Scientific reported an administrative update on its pending merger with Strive, Inc.. The company filed an 8-K to provide supplemental disclosures about Strive in Exhibit 99.1, tied to the previously announced all-stock acquisition of Semler by Strive under a merger agreement dated September 22, 2025.
The update reiterates that Strive has filed a Form S-4 registering Class A common stock to be issued in the transaction, which will include an information statement/proxy statement/prospectus to be sent to Semler stockholders for voting. The filing emphasizes standard forward‑looking statement cautions and directs investors to SEC and company websites for the S-4 and related materials.
FAQ
What is the current stock price of Semler Scientific (SMLR)?
What is the market cap of Semler Scientific (SMLR)?
